Bell Investment Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$373K Sell
1,468
-39
-3% -$9.09K 0.05% 100
2026
Q1
$368K Buy
1,507
+30
+2% +$6.99K 0.06% 96
2025
Q4
$306K Buy
1,477
+105
+8% +$20.8K 0.05% 98
2025
Q3
$254K Sell
1,372
-299
-18% -$51.2K 0.04% 108
2025
Q2
$255K Buy
1,671
+555
+50% +$85.3K 0.04% 105
2025
Q1
$185K Buy
1,116
+244
+28% +$38.2K 0.03% 112
2024
Q4
$126K Buy
872
+115
+15% +$17.8K 0.02% 128
2024
Q3
$123K Buy
757
+167
+28% +$26.6K 0.02% 130
2024
Q2
$86.2K Sell
590
-380
-39% -$56.5K 0.02% 157
2024
Q1
$153K Buy
970
+393
+68% +$62.6K 0.03% 112
2023
Q4
$90.4K Sell
577
-140
-20% -$21.5K 0.02% 141
2023
Q3
$112K Sell
717
-186
-21% -$30.7K 0.03% 113
2023
Q2
$149K Buy
903
+282
+45% +$45.5K 0.03% 90
2023
Q1
$96.3K Sell
621
-510
-45% -$82.4K 0.02% 102
2022
Q4
$200K Buy
1,131
+492
+77% +$85K 0.05% 79
2022
Q3
$104K Buy
639
+12
+2% +$2.03K 0.03% 81
2022
Q2
$111K Buy
+627
New +$112K 0.03% 86
2021
Q4
$116K Buy
681
+209
+44% +$34.2K 0.03% 95
2021
Q3
$76K Buy
+472
New +$80.5K 0.02% 109

Other funds holding JNJ

Bell Investment Advisors's JNJ Position: Q2 2026 in Review

Bell Investment Advisors reduced its Johnson & Johnson (JNJ) stake by 2.6% in Q2 2026, selling an estimated $9.09K and leaving 1,468 shares worth $373K. The position accounts for 0.05% of the portfolio, ranked #100.

Bell Investment Advisors first reported a position in JNJ in Q3 2021 and has held it in 19 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Bell Investment Advisors held 1,468 shares of Johnson & Johnson worth $373K as of Q2 2026.
  • Bell Investment Advisors sold 39 Johnson & Johnson shares in Q2 2026, an estimated $9.09K.
  • Johnson & Johnson made up 0.05% of Bell Investment Advisors's portfolio in Q2 2026, its #100 holding.
  • Bell Investment Advisors first reported a position in Johnson & Johnson in Q3 2021 and has held it in 19 quarters since.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.